# MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR

> **NCT03705312** · NA · UNKNOWN · sponsor: **Montreal Heart Institute** · enrollment: 174 (estimated)

## Conditions studied

- Mitral Regurgitation
- Heart Failure
- Mitral Valve Regurgitation Due to Cardiomyopathy (Disorder)

## Interventions

- **DEVICE:** Transcatheter mitral valve repair
- **OTHER:** Guideline-directed medical therapy

## Key facts

- **NCT ID:** NCT03705312
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-22
- **Primary completion:** 2021-12
- **Final completion:** 2022-01
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2019-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03705312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03705312, "MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03705312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*